FDA OKs Lupin's arthritis drug
This article was originally published in Scrip
Executive Summary
The US FDA granted approval to Lupin's nabumetone 500mg and 750mg strength tablets to treat acute and chronic signs and symptoms of osteoarthritis and rheumatoid arthritis.